Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule-associated protein 9 (MAP9), also known as ASAP (Aster-associated protein), is an essential protein for proper cell cycle progression and organization of the bipolar mitotic spindle[1][3][4]. It is required for spindle function, mitosis progression, and cytokinesis, and may also play a role in stabilizing interphase microtubules[3][4]. MAP9 is strongly expressed in tissues rich in microtubules, such as brain and testis, and localizes to microtubules and the mitotic spindle during cell division[1]. It has conserved domains involved in microtubule interaction and can be regulated by phosphorylation through Aurora-A kinase; its expression and proper function are critical for normal mitosis and prevention of aneuploidy and cell death. Disruption of MAP9 leads to mitotic defects, chromosome missegregation, and defective cytokinesis[1]. MAP9 may represent a potential novel target for antitumor therapies and is of interest in neurodegenerative disease pathways due to its role in neuronal microtubule dynamics[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule-associated protein 9 (MAP9).